High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors

Overlap in morphologic features between malignant and benign myogenic tumors, such as leiomyosarcoma (LMS) vs. leiomyoma as well as rhabdomyosarcoma (RMS) vs. rhabdomyoma, often makes differential diagnosis difficult and challenging. Here the expressions of Enhancer of Zeste Homolog 2 (EZH2), Suppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ning, Zeng, Zhi, Li, Shaobo, Wang, Fei, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098067/
https://www.ncbi.nlm.nih.gov/pubmed/30120321
http://dx.doi.org/10.1038/s41598-018-30648-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098067/
https://www.ncbi.nlm.nih.gov/pubmed/30120321
http://dx.doi.org/10.1038/s41598-018-30648-7

Ejemplares similares